胎儿监护市场机会、成长动力、产业趋势分析及 2025-2034 年预测

2024 年全球胎儿监护市场规模达到 58 亿美元，预计 2025 年至 2034 年复合年增长率为 6.8%，这得益于对先进产妇保健解决方案的需求不断增长。人们对妊娠相关併发症的认识不断提高以及早期发现胎儿窘迫的需求是推动市场成长的关键因素。随着医疗保健提供者强调积极主动的产妇和胎儿护理，创新监测技术的采用正在加速。

医疗技术的不断进步正在改变胎儿监护，使其更加精确、高效和方便。增强的感测器精确度、即时监控能力以及人工智慧驱动的分析正在透过早期诊断和介入彻底改变产前护理。这些创新不仅改善了怀孕结果，也降低了併发症的风险，确保了更好的整体孕产妇和胎儿健康。远端监控和远距医疗解决方案的日益整合进一步提高了可近性，特别是在医疗保健基础设施有限的地区。随着数位医疗的普及，医疗保健提供者正在利用数据驱动的洞察力来提供个人化和及时的干预。

便携性仍然是市场区隔的关键因素，将设备分为便携式和非便携式两类。 2024年，便携式胎儿监护设备由于其便利性和移动性将占据37.9%的市场。预计到 2034 年，该领域的复合年增长率将达到 6.9%，反映出人们对家庭和门诊胎儿监护的偏好日益增长。便携式设备能够持续监测，无需频繁去医院，从而增强了医疗专业人员和准妈妈的产前护理管理。因此，这些解决方案简化了产妇保健服务，同时减轻了医院设施的负担。

依方法细分，凸显了非侵入性胎儿监测相较于传统侵入性技术的日益受到青睐。 2024 年，非侵入式解决方案占据市场主导地位，占有 76% 的份额，预计该领域将在未来几年见证最高成长。非侵入性技术提供准确的胎儿监测，同时消除与侵入性方法相关的风险，例如感染和出血。对安全、高效、舒适的监测解决方案的需求不断增长，这加强了向非侵入性选择的转变，尤其是在发达的医疗保健市场。

美国仍然是全球胎儿监护产业的主导者，2024 年的收入将达到 20 亿美元。妊娠相关併发症发生率的增加是推动全国需求的主要因素。随着医疗保健系统注重风险管理和早期干预，先进的胎儿监护解决方案的采用不断扩大。人工智慧诊断和无线监控的整合进一步加强了市场成长，提高了患者护理标准，同时优化了医疗资源。随着不断创新和支持性监管框架的出现，美国胎儿监护市场将在未来十年持续扩张。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 妊娠相关併发症发生率不断上升
    • 胎儿监测设备的技术进步
    • 政府不断推出旨在促进母婴健康的倡议
    • 非侵入式设备的采用激增
    • 早产数量增加，不孕症治疗采用率上升
  • 产业陷阱与挑战
    • 设备成本高
    • 翻新产品的可用性
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略展望

第五章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 超音波设备
  • 二维超音波
  • 3D和4D超音波
  • 多普勒成像
• 电子胎儿监视器（EFM）
  • 外部 EFM
  • 内部 EFM
• 子宫收缩监测仪
• 配件和耗材
• 其他产品

第六章：市场估计与预测：按便携性，2021 年至 2034 年

• 主要趋势
• 便携的
• 非便携式

第七章：市场估计与预测：依方法，2021 年至 2034 年

• 主要趋势
• 侵入性
• 非侵入性

第八章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 专科诊所
• 其他最终用途

第九章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• Becton, Dickinson and Company
• Biolight Medical
• Cardinal Health
• DOTO Health
• EDAN Instrument
• FUJIFILM Holdings Corporation
• GE Healthcare
• Huntleigh Healthcare (Arjo)
• Koninklijke Philips
• MedGyn products
• Medtronic
• Natus Medical
• Neoventa Medical
• Siemens Healthineers
• Spacelabs Healthcare

The Global Fetal Monitoring Market reached USD 5.8 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2034, driven by the increasing demand for advanced maternal healthcare solutions. Rising awareness of pregnancy-related complications and the need for early detection of fetal distress are key factors propelling market growth. As healthcare providers emphasize proactive maternal and fetal care, the adoption of innovative monitoring technologies is accelerating.

Continuous advancements in medical technology are transforming fetal monitoring, making it more precise, efficient, and accessible. Enhanced sensor accuracy, real-time monitoring capabilities, and AI-driven analytics are revolutionizing prenatal care by enabling early diagnosis and intervention. These innovations not only improve pregnancy outcomes but also reduce the risk of complications, ensuring better overall maternal and fetal health. The growing integration of remote monitoring and telehealth solutions further enhances accessibility, particularly in regions with limited healthcare infrastructure. As digital health adoption rises, healthcare providers are leveraging data-driven insights to deliver personalized and timely interventions.

Portability remains a crucial factor in market segmentation, distinguishing devices into portable and non-portable categories. In 2024, portable fetal monitoring devices accounted for 37.9% of the market share, driven by their convenience and mobility. This segment is projected to grow at a CAGR of 6.9% through 2034, reflecting a rising preference for home-based and outpatient fetal monitoring. Portable devices enable continuous monitoring without frequent hospital visits, enhancing prenatal care management for both healthcare professionals and expectant mothers. As a result, these solutions are streamlining maternal healthcare services while reducing the burden on hospital facilities.

Segmentation by method highlights the increasing preference for non-invasive fetal monitoring over traditional invasive techniques. In 2024, non-invasive solutions dominated the market with a 76% share, and this segment is expected to witness the highest growth in the coming years. Non-invasive technologies offer accurate fetal monitoring while eliminating risks associated with invasive methods, such as infections and bleeding. The growing demand for safe, efficient, and comfortable monitoring solutions is reinforcing the shift toward non-invasive options, particularly in developed healthcare markets.

The United States remains a dominant player in the global fetal monitoring industry, generating USD 2 billion in revenue in 2024. The increasing incidence of pregnancy-related complications is a primary factor driving demand across the country. As healthcare systems focus on risk management and early intervention, the adoption of advanced fetal monitoring solutions continues to expand. The integration of AI-powered diagnostics and wireless monitoring further strengthens market growth, enhancing patient care standards while optimizing healthcare resources. With continuous innovation and supportive regulatory frameworks, the US fetal monitoring market is poised for sustained expansion in the coming decade.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of pregnancy-related complications
    • 3.2.1.2 Technological advancements in fetal monitoring devices
    • 3.2.1.3 Rising government initiatives aimed at promoting maternal and child health
    • 3.2.1.4 Surge in adoption of non-invasive devices
    • 3.2.1.5 Increasing number of preterm births and rising adoption of infertility treatment
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Availability of refurbished products
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Ultrasound devices
  • 5.2.1 2D ultrasound
  • 5.2.2 3D and 4D ultrasound
  • 5.2.3 Doppler imaging
• 5.3 Electronic fetal monitoring (EFM)
  • 5.3.1 External EFM
  • 5.3.2 Internal EFM
• 5.4 Uterine contraction monitor
• 5.5 Accessories and consumables
• 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Portability, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Portable
• 6.3 Non-portable

Chapter 7 Market Estimates and Forecast, By Method, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Invasive
• 7.3 Non-invasive

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Specialty clinics
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Becton, Dickinson and Company
• 10.2 Biolight Medical
• 10.3 Cardinal Health
• 10.4 DOTO Health
• 10.5 EDAN Instrument
• 10.6 FUJIFILM Holdings Corporation
• 10.7 GE Healthcare
• 10.8 Huntleigh Healthcare (Arjo)
• 10.9 Koninklijke Philips
• 10.10 MedGyn products
• 10.11 Medtronic
• 10.12 Natus Medical
• 10.13 Neoventa Medical
• 10.14 Siemens Healthineers
• 10.15 Spacelabs Healthcare